Hillan Kenneth J. Insider Trades

Insider Trading History

Track insider trading activity for Hillan Kenneth J.. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Sangamo Therapeutics
Sangamo Therapeutics SGMO
Director
Holding Value $7.28k 99,600 shares
Last Trade
Jun 12, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$25k 50,000 shares
$0.50
$0.07
Sangamo Therapeutics
Sangamo Therapeutics SGMO
Director
Holding Value $5.45k 74,600 shares
Last Trade
Jun 04, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$28.5k 50,000 shares
$0.57
$0.07
Zymeworks BC
Zymeworks BC ZYME
Director
Holding Value $884k 37,000 shares
Last Trade
Dec 07, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$353k 37,000 shares
$9.55
$23.88
23andMe Holding
23andMe Holding ME
Chief Therapeutics Officer
Holding Value $144k 237,223 shares
Last Trade
Jun 05, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.85M 44,381 shares
$41.60
$0.61
23andMe Holding Co - Warrants (16/06/2026)
23andMe Holding Co - Warrants (16/06/2026) MEUSW
Chief Therapeutics Officer
Holding Value $327k 237,223 shares
Last Trade
Jun 05, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$76.3k 44,381 shares
$1.72
$1.38
23andMe Holding
23andMe Holding ME
Chief Therapeutics Officer
Holding Value $135k 221,876 shares
Last Trade
Jun 05, 2023 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$638k 15,347 shares
$41.60
$0.61
23andMe Holding Co - Warrants (16/06/2026)
23andMe Holding Co - Warrants (16/06/2026) MEUSW
Chief Therapeutics Officer
Holding Value $306k 221,876 shares
Last Trade
Jun 05, 2023 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$26.4k 15,347 shares
$1.72
$1.38
Sangamo Therapeutics
Sangamo Therapeutics SGMO
Director
Holding Value $3.63k 49,600 shares
Last Trade
Jun 01, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$30.8k 27,750 shares
$1.11
$0.07
23andMe Holding
23andMe Holding ME
Chief Therapeutics Officer
Holding Value $117k 192,842 shares
Last Trade
May 20, 2023 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$180k 4,628 shares
$38.80
$0.61
23andMe Holding Co - Warrants (16/06/2026)
23andMe Holding Co - Warrants (16/06/2026) MEUSW
Chief Therapeutics Officer
Holding Value $266k 192,842 shares
Last Trade
May 20, 2023 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$7.96k 4,628 shares
$1.72
$1.38
23andMe Holding Co - Warrants (16/06/2026)
23andMe Holding Co - Warrants (16/06/2026) MEUSW
Chief Therapeutics Officer
Holding Value $265k 191,705 shares
Last Trade
Feb 20, 2023 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$9.39k 5,457 shares
$1.72
$1.38
23andMe Holding
23andMe Holding ME
Chief Therapeutics Officer
Holding Value $116k 191,705 shares
Last Trade
Feb 20, 2023 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$313k 5,457 shares
$57.40
$0.61
Zymeworks BC
Zymeworks BC ZYME
Director
Holding Value $597k 25,000 shares
Last Trade
Dec 21, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$219k 25,000 shares
$8.75
$23.88
23andMe Holding
23andMe Holding ME
Chief Therapeutics Officer
Holding Value $120k 197,162 shares
Last Trade
Nov 20, 2022 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$277k 4,628 shares
$59.80
$0.61
23andMe Holding Co - Warrants (16/06/2026)
23andMe Holding Co - Warrants (16/06/2026) MEUSW
Chief Therapeutics Officer
Holding Value $272k 197,162 shares
Last Trade
Nov 20, 2022 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$7.96k 4,628 shares
$1.72
$1.38
23andMe Holding Co - Warrants (16/06/2026)
23andMe Holding Co - Warrants (16/06/2026) MEUSW
Chief Therapeutics Officer
Holding Value $271k 196,083 shares
Last Trade
Aug 24, 2022 Sale (Open Market)Shares sold on the open market or in a private sale.
$15.1k 8,753 shares
$1.72
$1.38
23andMe Holding
23andMe Holding ME
Chief Therapeutics Officer
Holding Value $119k 196,083 shares
Last Trade
Aug 24, 2022 Sale (Open Market)Shares sold on the open market or in a private sale.
$642k 8,753 shares
$73.40
$0.61
23andMe Holding
23andMe Holding ME
Chief Therapeutics Officer
Holding Value $124k 204,836 shares
Last Trade
Aug 20, 2022 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$308k 4,628 shares
$66.60
$0.61
23andMe Holding Co - Warrants (16/06/2026)
23andMe Holding Co - Warrants (16/06/2026) MEUSW
Chief Therapeutics Officer
Holding Value $283k 204,836 shares
Last Trade
Aug 20, 2022 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$7.96k 4,628 shares
$1.72
$1.38
23andMe Holding Co - Warrants (16/06/2026)
23andMe Holding Co - Warrants (16/06/2026) MEUSW
Chief Therapeutics Officer
Holding Value $289k 209,464 shares
Last Trade
Jun 01, 2022 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$7.96k 4,627 shares
$1.72
$1.38

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up